ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
WHO recommends dolutegravir as preferred HIV treatment option biospectrumasia
July 23, 2019Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations, including pregnant women and those of childbearing potential. ?
Pharma Sources Insight January 2025
